Biology Reference
In-Depth Information
Butcher RW, Sutherland EW (1962) Adenosine 3
0
,5
0
-phosphate in biological materials. I. Purifi-
cation and properties of cyclic 3
0
,5
0
-nucleotide phosphodiesterase and use of this enzyme to
characterize adenosine 3
0
,5
0
-phosphate in human urine. J Biol Chem 237:1244-1250
Butt E, Beltman J, Becker DE, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA (1995) Characteriza-
tion of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic
sites and comparison with other cyclic AMP-binding proteins. Mol Pharmacol 47:340-347
Castro LR, Verde I, Cooper DM, Fischmeister R (2006) Cyclic guanosine monophosphate
compartmentation in rat cardiac myocytes. Circulation 113:2221-2228
Charbonneau H (1990) Structure-function relationships among cyclic nucleotide phosphodies-
terases. In: Beavo J, Houslay MD (eds) Cyclic nucleotide phosphodiesterases: structure,
regulation and drug action. Wiley, New York, pp 267-296
Chen G, Wang H, Robinson H, Cai J, Wan Y, Ke H (2008) An insight into the pharmacophores of
phosphodiesterase-5 inhibitors from synthetic and crystal structural studies. Biochem Pharmacol
75:1717-1728
Cheung PP, Yu L, Zhang H, Colman RW (1998) Partial characterization of the active site human
platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis. Arch Biochem Bio-
phys 360:99-104
Collins DM, Murdoch H, Dunlop AJ, Charych E, Baillie GS, Herberg FW, Brandon N, Prinz A,
Houslay MD (2008) Ndel1 alters its conformation by sequestering cAMP-specific phosphodi-
esterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A
(PKA). Cell Signal 20:2356-2369
Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases:
essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C (2003) Cyclic AMP-specific PDE4
phosphodiesterases as critical components of cyclic AMP signaling.
J Biol Chem
278:5493-5496
Corbin JD, Francis SH (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem
274:13729-13732
Corbin JD, Sugden PH, Lincoln TM, Keely SL (1977) Compartmentalization of adenosine 3
0
:5
0
-
monophosphate and adenosine 3
0
:5
0
-monophosphate-dependent protein kinase in heart tissue.
J Biol Chem 252:3854-3861
Corbin JD, Turko IV, Beasley A, Francis SH (2000) Phosphorylation of phosphodiesterase-5 by
cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding
activities. Eur J Biochem 267:2760-2767
Corbin JD, Blount MA, Weeks JL 2nd, Beasley A, Kuhn KP, Ho YS, Saidi LF, Hurley JH, Kotera
J, Francis SH (2003) [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically
heterogeneous, and stimulated by cGMP. Mol Pharmacol 63:1364-1372
Cortijo J, Bou J, Beleta J, Cardelus I, Llenas J, Morcillo E, Gristwood RW (1993) Investigation
into the role of phosphodiesterase IV in bronchorelaxation, including studies with human
bronchus. Br J Pharmacol 108:562-568
CoteRH(2006)Photoreceptorphosphodiesterase(PDE6):aG-protein-activatedPDEregulatingvisual
excitation in rod and cone photoreceptor cells. In: Beavo J, Francis SH, HouslayMD (eds) Cyclic
nucleotidephosphodiesterasesinhealthanddisease.CRCPress,BocaRaton,pp165-193
Dent G, Rabe K (1996) Effects of theophylline and non-selective xanthine derivatives on PDE
isoenzymes and cellular function. In: Schudt C, Dent G, Rabe KF (eds) Handbook of immu-
nopharmacology: phosphodiesterase inhibitors. Academic, San Diego, pp 41-64
Erneux C, Miot F, Boeynaems JM, Dumont JE (1982) Paradoxical stimulation by 1-methyl-3-
isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity. FEBS Lett 142:251-254
Fink TL, Francis SH, Beasley A, Grimes KA, Corbin JD (1999) Expression of an active,
monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase
(PDE5). J Biol Chem 274:34613-34620
Francis SH, Corbin JD (1999) Cyclic nucleotide-dependent protein kinases: intracellular receptors
for cAMP and cGMP action. Crit Rev Clin Lab Sci 36:275-328
